For a generation, fish oil in pregnancy has been treated as a quiet act of care — a mother giving her child a biochemical head start. Now, a decade-long Danish trial following nearly seven hundred children has complicated that story, finding that prenatal omega-3 supplementation may be linked to higher body weight and metabolic strain in offspring by age ten. The randomized controlled trial, long considered medicine's most reliable instrument of truth, has turned a widely trusted assumption into an open question — and reminded us that the body's response to intervention rarely follows a straig
Fish oil supplements in pregnancy linked to weight gain, metabolic risks in children
Potential long-term metabolic health consequences for children exposed to fish oil supplementation in utero, affecting growth trajectories and disease risk.
A supplement widely promoted for health benefits now appears potentially counterproductive
Mark
Why would fish oil, which we know has anti-inflammatory properties, lead to worse metabolic outcomes in children?
Mimi
That's the central mystery here. The researchers don't have a clear answer yet. It's possible that the dose, timing, or the specific form of supplementation matters in ways we don't yet understand. Or perhaps the effect is indirect—something about how the supplement alters the intrauterine environment in a way that programs the child's metabolism differently.
Mark
Did the mothers who took fish oil have different health outcomes themselves?
Mimi
The study doesn't report on that. The focus was entirely on the children at age ten. But it's a fair question—we don't know if the mothers experienced any changes in their own metabolic health or pregnancy outcomes.
Mark
The differences in BMI shrank when they adjusted for maternal BMI and other factors. Does that mean the effect isn't real?
Mimi
Not necessarily. Adjustment for confounders is standard statistical practice, but it doesn't erase the raw finding. The children in the fish oil group were measurably heavier. The question is whether that's a direct effect of the supplement or whether it's explained by other variables. The metabolic syndrome scores, though, pointed toward unhealthier metabolism even after adjustment.
Mark
What happens to these children after age ten?
Mimi
We don't know yet. This is a follow-up study of an earlier trial that looked at the same children at age six. The researchers are presumably continuing to track them, but longer-term outcomes haven't been published. That's crucial information—does this metabolic disadvantage persist, worsen, or resolve as they get older?
Mark
Should pregnant women stop taking fish oil supplements immediately?
Mimi
The study suggests caution, but it's not a blanket condemnation. One trial, even a well-designed one, warrants further investigation before changing clinical guidelines. But it does mean the assumption that fish oil is universally beneficial in pregnancy needs to be questioned and studied more carefully.
Le Pouls
- A supplement embraced by expectant mothers and endorsed by many physicians has been implicated in the very metabolic risks it was believed to prevent.
- Children born to mothers who took fish oil during their third trimester arrived at age ten with higher BMIs and greater overweight risk than those in the placebo group.
- Metabolic syndrome scores — a composite signal of systemic health — were elevated in the fish oil group even when individual markers like blood pressure and cholesterol appeared normal.
- Researchers could not explain the effect away: differences in diet, activity, puberty timing, and sex all failed to account for the pattern.
- The finding lands not as settled science but as an urgent call to pause — to reconsider supplementation guidelines before the next generation of prenatal advice is written.
For a generation, fish oil in pregnancy has been treated as a quiet act of care — a mother giving her child a biochemical head start. Now, a decade-long Danish trial following nearly seven hundred children has complicated that story, finding that prenatal omega-3 supplementation may be linked to higher body weight and metabolic strain in offspring by age ten. The randomized controlled trial, long considered medicine's most reliable instrument of truth, has turned a widely trusted assumption into an open question — and reminded us that the body's response to intervention rarely follows a straight line.
A study following nearly seven hundred children over ten years has challenged one of pregnancy nutrition's most comfortable assumptions. Researchers from the Copenhagen Prospective Studies on Asthma in Childhood enrolled 736 pregnant women at twenty-four weeks, giving half a daily dose of fish oil and half an identical olive oil placebo, continuing through one week postpartum. When 688 of those children were assessed at age ten, the results were unexpected: those exposed to fish oil in utero had significantly higher body mass indices and a greater likelihood of being overweight.
Published in The American Journal of Clinical Nutrition, the findings directly contradict earlier observational research and animal studies that had positioned omega-3 fatty acids as protective against childhood weight gain and metabolic problems. This trial — a randomized controlled design, the most rigorous standard in medical evidence — tells a different story.
Children in the fish oil group showed higher lean and fat mass, though some of these differences softened when accounting for maternal weight, smoking, and breastfeeding duration. More striking was the metabolic syndrome score: even without significant changes in glucose, cholesterol, or blood pressure individually, the composite measure of metabolic health was worse among fish oil-exposed children. The researchers found no explanation in lifestyle factors, diet, or the timing of puberty, and the pattern held equally across boys and girls.
The mechanism remains unknown. What is clear is that a supplement long promoted as a straightforward benefit during pregnancy may carry consequences that only surface years later — leaving physicians and expectant mothers with a harder, more uncertain conversation ahead.
A decade-long study following nearly seven hundred children has upended a widely held assumption about fish oil in pregnancy. Researchers tracking offspring from the Copenhagen Prospective Studies on Asthma in Childhood found that mothers who took fish oil supplements during their third trimester gave birth to children who, by age ten, carried more weight and showed signs of metabolic strain compared to children whose mothers took placebos.
The trial enrolled 736 pregnant women at the twenty-four-week mark, dividing them into two groups. One group received 2.4 grams daily of n-3 long-chain polyunsaturated fatty acids—the active compounds in fish oil—while the other received identical-looking capsules of olive oil. The supplementation continued until one week after delivery. When researchers assessed 688 of these children a decade later, the pattern was clear: those exposed to fish oil in utero had significantly higher body mass indices and were at greater risk of being overweight than their peers in the control group.
The findings, published in The American Journal of Clinical Nutrition, contradict earlier observational research suggesting that omega-3 fatty acids consumed during pregnancy protect children from excess weight gain and metabolic problems. Animal studies and human surveys had pointed toward fish oil as beneficial, leading many doctors and expectant mothers to view supplementation as a straightforward health measure. This randomized controlled trial—the gold standard of medical evidence—tells a different story.
When researchers looked more closely at body composition, children in the fish oil group showed higher amounts of both lean mass and fat mass, though these differences narrowed when accounting for factors like the mother's pre-pregnancy weight, smoking during pregnancy, and how long the child was exclusively breastfed. More striking were the metabolic syndrome scores, a composite measure of metabolic health. Children exposed to fish oil in utero scored higher on this measure, suggesting a tendency toward unhealthier metabolism, even though individual markers like blood glucose, cholesterol, and blood pressure showed no significant differences between groups.
The researchers ruled out several potential explanations for the effect. Physical activity levels, eating habits, and the timing of puberty did not account for the differences. The pattern held equally for boys and girls. The mechanism remains unclear—why a supplement widely promoted for its health benefits during pregnancy would appear to increase metabolic risk in offspring is not yet understood.
This is not a small or marginal finding. The study involved a large, well-designed cohort followed over a meaningful span of time, with careful measurement of multiple health outcomes. The results suggest that prenatal fish oil supplementation may carry unintended consequences that emerge years after exposure. For expectant mothers considering supplements and for physicians advising them, the implications are significant. The conventional wisdom that more omega-3 fatty acids during pregnancy is inherently protective now appears incomplete at best, and potentially counterproductive. What remains is the harder work of understanding why.
Citations marquantes
Fish oil or LCPUFA supplementation during pregnancy may have negative health impacts on the offspring— Study authors, The American Journal of Clinical Nutrition
Envie de l'histoire complète ?
Lire l'original sur News-Medical.net ↗
Health & Medicine